Cargando…

Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons

PURPOSE: Proton beam radiotherapy (PBT) has been used for the definitive treatment of localized prostate cancer with low rates of high-grade toxicity and excellent patient-reported quality-of-life metrics. Technological advances such as pencil beam scanning (PBS), Monte Carlo dose calculations, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Forsthoefel, Matthew, Hankins, Ryan, Ballew, Elizabeth, Frame, Cara, DeBlois, David, Pang, Dalong, Krishnan, Pranay, Unger, Keith, Kowalczyk, Keith, Lynch, John, Dritschilo, Anatoly, Collins, Sean P., Lischalk, Jonathan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238133/
https://www.ncbi.nlm.nih.gov/pubmed/35774493
http://dx.doi.org/10.14338/IJPT-21-00039
_version_ 1784736963173023744
author Forsthoefel, Matthew
Hankins, Ryan
Ballew, Elizabeth
Frame, Cara
DeBlois, David
Pang, Dalong
Krishnan, Pranay
Unger, Keith
Kowalczyk, Keith
Lynch, John
Dritschilo, Anatoly
Collins, Sean P.
Lischalk, Jonathan W.
author_facet Forsthoefel, Matthew
Hankins, Ryan
Ballew, Elizabeth
Frame, Cara
DeBlois, David
Pang, Dalong
Krishnan, Pranay
Unger, Keith
Kowalczyk, Keith
Lynch, John
Dritschilo, Anatoly
Collins, Sean P.
Lischalk, Jonathan W.
author_sort Forsthoefel, Matthew
collection PubMed
description PURPOSE: Proton beam radiotherapy (PBT) has been used for the definitive treatment of localized prostate cancer with low rates of high-grade toxicity and excellent patient-reported quality-of-life metrics. Technological advances such as pencil beam scanning (PBS), Monte Carlo dose calculations, and polyethylene glycol gel rectal spacers have optimized prostate proton therapy. Here, we report the early clinical outcomes of patients treated for localized prostate cancer using modern PBS–PBT with hydrogel rectal spacing and fiducial tracking without the use of endorectal balloons. MATERIALS AND METHODS: This is a single institutional review of consecutive patients treated with histologically confirmed localized prostate cancer. Prior to treatment, all patients underwent placement of fiducials into the prostate and insertion of a hydrogel rectal spacer. Patients were typically given a prescription dose of 7920 cGy at 180 cGy per fraction using a Monte Carlo dose calculation algorithm. Acute and late toxicity were evaluated using the Common Terminology Criteria for Adverse Events (CTCAE), version 5. Biochemical failure was defined using the Phoenix definition. RESULTS: From July 2018 to April 2020, 33 patients were treated (median age, 75 years). No severe acute toxicities were observed. The most common acute toxicity was urinary frequency. With a median follow-up of 18 months, there were no high-grade genitourinary late toxicities; however, one grade 3 gastrointestinal toxicity was observed. Late erectile dysfunction was common. One treatment failure was observed at 21 months in a patient treated for high-risk prostate cancer. CONCLUSION: Early clinical outcomes of patients treated with PBS–PBT using Monte Carlo–based planning, fiducial placement, and rectal spacers sans endorectal balloons demonstrate minimal treatment-related toxicity with good oncologic outcomes. Rectal spacer stabilization without the use of endorectal balloons is feasible for the use of PBS–PBT.
format Online
Article
Text
id pubmed-9238133
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Particle Therapy Co-operative Group
record_format MEDLINE/PubMed
spelling pubmed-92381332022-06-29 Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons Forsthoefel, Matthew Hankins, Ryan Ballew, Elizabeth Frame, Cara DeBlois, David Pang, Dalong Krishnan, Pranay Unger, Keith Kowalczyk, Keith Lynch, John Dritschilo, Anatoly Collins, Sean P. Lischalk, Jonathan W. Int J Part Ther Original Articles PURPOSE: Proton beam radiotherapy (PBT) has been used for the definitive treatment of localized prostate cancer with low rates of high-grade toxicity and excellent patient-reported quality-of-life metrics. Technological advances such as pencil beam scanning (PBS), Monte Carlo dose calculations, and polyethylene glycol gel rectal spacers have optimized prostate proton therapy. Here, we report the early clinical outcomes of patients treated for localized prostate cancer using modern PBS–PBT with hydrogel rectal spacing and fiducial tracking without the use of endorectal balloons. MATERIALS AND METHODS: This is a single institutional review of consecutive patients treated with histologically confirmed localized prostate cancer. Prior to treatment, all patients underwent placement of fiducials into the prostate and insertion of a hydrogel rectal spacer. Patients were typically given a prescription dose of 7920 cGy at 180 cGy per fraction using a Monte Carlo dose calculation algorithm. Acute and late toxicity were evaluated using the Common Terminology Criteria for Adverse Events (CTCAE), version 5. Biochemical failure was defined using the Phoenix definition. RESULTS: From July 2018 to April 2020, 33 patients were treated (median age, 75 years). No severe acute toxicities were observed. The most common acute toxicity was urinary frequency. With a median follow-up of 18 months, there were no high-grade genitourinary late toxicities; however, one grade 3 gastrointestinal toxicity was observed. Late erectile dysfunction was common. One treatment failure was observed at 21 months in a patient treated for high-risk prostate cancer. CONCLUSION: Early clinical outcomes of patients treated with PBS–PBT using Monte Carlo–based planning, fiducial placement, and rectal spacers sans endorectal balloons demonstrate minimal treatment-related toxicity with good oncologic outcomes. Rectal spacer stabilization without the use of endorectal balloons is feasible for the use of PBS–PBT. The Particle Therapy Co-operative Group 2022-04-06 /pmc/articles/PMC9238133/ /pubmed/35774493 http://dx.doi.org/10.14338/IJPT-21-00039 Text en ©Copyright 2022 The Author(s) https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed in accordance with Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ).
spellingShingle Original Articles
Forsthoefel, Matthew
Hankins, Ryan
Ballew, Elizabeth
Frame, Cara
DeBlois, David
Pang, Dalong
Krishnan, Pranay
Unger, Keith
Kowalczyk, Keith
Lynch, John
Dritschilo, Anatoly
Collins, Sean P.
Lischalk, Jonathan W.
Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons
title Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons
title_full Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons
title_fullStr Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons
title_full_unstemmed Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons
title_short Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons
title_sort prostate cancer treatment with pencil beam proton therapy using rectal spacers sans endorectal balloons
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238133/
https://www.ncbi.nlm.nih.gov/pubmed/35774493
http://dx.doi.org/10.14338/IJPT-21-00039
work_keys_str_mv AT forsthoefelmatthew prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT hankinsryan prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT ballewelizabeth prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT framecara prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT debloisdavid prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT pangdalong prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT krishnanpranay prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT ungerkeith prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT kowalczykkeith prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT lynchjohn prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT dritschiloanatoly prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT collinsseanp prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons
AT lischalkjonathanw prostatecancertreatmentwithpencilbeamprotontherapyusingrectalspacerssansendorectalballoons